News

Jun 14, 2022

We are delighted to invite ESCAP 2022 attendees to participate in our satellite symposium “Screen, Evaluate and Treat Insomnia in Children with ASD” on Monday, June 20th at 12:30. (Read more)

May 31, 2022

We are excited and inspired to meet our partners F2F again! (Read more)

Mar 9, 2022

Slenyto is now available in Spain!

Mar 2, 2022

Neurim Pharmaceuticals is attending World Sleep Congress 2022, March 11-16, Rome, Italy (Read more)

Feb 8, 2022

Neurim conducted a survey via Brandman Research, assessing the characteristics of insomnia in children with ASD and the distress it causes to the children and their families (Read more)

Jan 17, 2022

Neurim collaborated with Azrieli National Center for Autism and Neurodevelopment Research to assess the burden of Insomnia in children with autism (Read more)

Oct 4, 2021

Slenyto is now available in Portugal!

Apr 22, 2020

Slenyto (PedPRM) is now available in France!

Feb 11, 2020

Slenyto (PedPRM) is now available in Denmark!

Jan 27, 2020

Slenyto (PedPRM) is now also available in Iceland!

Jan 14, 2020

Slenyto (PedPRM) is now available in Switzerland!

Sep 18, 2019

Slenyto (PedPRM) is now available in Norway!

Jun 27, 2019

Neurim Pharmaceuticals attends the ESCAP Congress in Vienna, Austria, 30 June – 2 July 2019

May 23, 2019

Slenyto (PedPRM) is now also available in Italy!

Apr 8, 2019

Neurim Pharmaceuticals attends the EPA Congress in Warsaw, Poland, April 7-9, 2019

Apr 3, 2019

Slenyto (PedPRM) is now also available in UK!

Apr 1, 2019

Slenyto is now available in Finland

Jan 27, 2019

Slenyto is now available in Germany